Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMEL1 | Q495T6 | 5/20 | 0.58 |
| ▸ | MME | P08473 | 11/20 | 0.57 |
| ▸ | ACE | P12821 | 5/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17746035 | 0.90 | MME (0.65) | MMEL1MMEACE | |
| SCHEMBL21239962 | 0.90 | MME (0.65) | MMEL1MMEACE | |
| SCHEMBL1908574 | 0.89 | MME (0.59) | MMEL1MMEACE | |
| SCHEMBL1909815 | 0.89 | MME (0.59) | MMEL1MMEACE | |
| SCHEMBL21727312 | 0.87 | MME (0.64) | MMEL1MMEACE | |
| SCHEMBL28190605 | 0.86 | MME (0.65) | MMEL1MMEACE | |
| Sacubitril SCHEMBL8214132 | 0.85 | MME (0.77) | MMEL1MMEACE | |
| Sacubitril SCHEMBL18059568 | 0.85 | MME (0.77) | MMEL1MMEACE | |
| Sacubitril SCHEMBL2707112 | 0.85 | MME (0.77) | MMEL1MMEACE | |
| Sacubitril SCHEMBL18059569 | 0.85 | MME (0.77) | MMEL1MMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109415308-B | Novel method for early-stage sabcomet intermediate | 诺华股份有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-108601741-B | Galenic formulations of organic compounds | 诺华股份有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-107980038-B | Calcium salt of Shakuba Trigonella | 诺华股份有限公司 | 2021-04-27 | — | — | CN | disclosed |
| CN-112574132-A | Preparation method of shakubiqu valsartan sodium | 广东东阳光药业有限公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-107250100-B | process and intermediates for preparing NEP inhibitors | 诺华股份有限公司 | 2019-12-06 | — | — | CN | disclosed |